Edap TMS, a medical device firm based in France, has submitted to the FDA a premarket approval application for its Ablatherm-HIFU system. The high-intensity focused ultrasound system is intended for the noninvasive treatment of patients with localized, low-risk prostate cancer.
Edap seeks FDA approval for prostate cancer device
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||